View Clinical Trial (Medical Research Study)


An fMRI Study Of Brain Response In Patients With Fibromyalgia - NCT00760474-48106(Clinical Trial 243378)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Ann Arbor
State:  
MI
Zip Code: 48106
Conditions: Fibromyalgia
Purpose: The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance imaging) is an efficient way to show whether new pain medications are effective in treating fibromyalgia.
Study summary: Methodology study
Criteria: Inclusion Criteria: - Women must have pain due to fibromyalgia - Fibromyalgia must have been diagnosed at least 6 months prior to be eligible for this study Exclusion Criteria: - Patients with severe depression or other serious illness, who are left-handed, or who are pregnant or nursing are not eligible for this study.
Study is available at: Pfizer Investigational Site
Ann Arbor, MI 48106
United States

Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.